March 21, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE:ACG; FWB:1LA) is pleased to report that the Company is in negotiations to acquire a majority interest in BC Maramed Production Ltd. (“BCMM”) which has submitted an application to become a Licensed Producer of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”).
Alliance Growers currently holds a 50% interest in BCMM which owns a leasehold interest and equipment for an 11,000-square foot production facility in Kelowna, British Columbia.
BCMM, has received and has replied to the Department of Health Canada on ACMPR application, who require additional information for security clearance including:
- External and internal security measures
- Updated site survey and aerial photographs
- Further information on principal and proposed technical employees
- Details on record keeping and information handling procedures
Alliance Growers is negotiating with current owners of the other 50% of BCMM to secure majority ownership and take control of the Application Process. This includes appointing a replacement Responsible Person In Charge and engaging an external specialist to assist in the application process. The Company is confident that once it controls the application process, utilizing specialists with the expertise in the industry combined with the high commercial standards of the production facility, that the application will be in full compliance with Department of Health requirements for a full commercial ACMPR license.
“If we can agree on favourable terms to acquire a majority stake in BCMM and bring in our own management team, then we will be able to reach the approval for our ACMPR in a timely manner. In the process, we will be better able to update shareholders on our continued progress, ” said Dennis Petke, Alliance Growers’ President and CEO.
Read the full company profile.
About Alliance Growers
Alliance Growers Corp is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Development.
Alliance Growers has executed an agreement with Botanical Research In Motion International Inc., for a Canada Exclusive License to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.
Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process. Additionally, the Company is investing in several cannabis industry participants, ranging from co-developing a Cannabis App for use by the cannabis industry and its markets, to negotiating business arrangements with several companies for the purchase and sale between the parties of live cannabis plants, tissue culture plantlets and other cannabis products and services.
For further information, please visit the Company’s corporate website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.
If you would like to be added to Alliance Growers’ news distribution list, please send your email address to email@example.com
On behalf of the board of directors of
ALLIANCE GROWERS CORP.
President and CEO
For more information contact:
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
Connect with Alliance Growers Corp. (CSE:ACG; FWB:1LA) to receive an Investor Presentation.
Mark Doucet has joined Valens GroWorks Corp. (CSE:VGW) as its president.
Mark Doucet has more than 25 years of senior executive experience. He has been involved in and advised on capital markets, infrastructure, commercial real estate, precious metals and other industries both foreign and domestic. Past service includes: President of a US junior exploration company, President of a business/government relations company, Founder and President of a wireless application company, and Vice President for several Canadian junior exploration companies, an international government/business consulting firm and an Atlantic Canada restaurant franchise. Mark served as Financial Officer and Development Planner for the privatization and redevelopment of Toronto’s Pearson International Airport. Mark and his wife have two boys, and reside in Ottawa.
Mark commented “Valens GroWorks Corp. has vastly superior products and people completely motivated to realize their vision of excellence by leading this quickly evolving industry. Drawing on this vision, I am passionately energized to help the Valens GroWorks team become an industry leader in this space.”
Robert van Santen, the Company’s CEO and Chair commented “I am particularly pleased that a seasoned and visionary leader like Mark has chosen our Company and its team as his vehicle to enter into this rapid-growth sector as the repeal of prohibition looms in Canada. The industry is in transition from the legacy world of commercial marijuana — legal, quasi-legal, gray market, illicit — to the future, which will see a fully institutionalized market.”
Read the full company profile.
The Company is granting stock options to acquire an aggregate of one million common shares in the capital of the Company at an exercise price of $1.40 per common share, expiring on the fifth anniversary of the grant (collectively, the “Stock Option”). The Stock Option vests in stages over the course of two (2) years with 12.5% to vest immediately and a further 12.5% to vest in each three-month period thereafter, and is exercisable quarterly after 12 months, with the balance after 24 months from the Commencement Date. The Stock Options are being granted in accordance with the Company’s stock option plan, and are subject to regulatory approval.
About Valens GroWorks Corp.
Valens GroWorks Corp is a Canadian Securities Exchange listed company with an aggressive acquisition strategy in progress, providing management, consulting, testing and support services to domestic and international licensees, as well as financing the buildout of established, fully-licensed operations pursuant to its investment in Arizona. The Company seeks to capture a broad spectrum of medical marijuana users, as well as recreational users once legalized, in pursuit of its ambitious seed to sale and farm to pharma objectives.
The Company’s wholly-owned subsidiary, Valens Agritech Ltd. (“VAL”), is a post-inspection applicant awaiting the granting of a Controlled Drugs and Substances Dealer’s Licence for the cultivation and processing of marijuana. Based in the Okanagan Valley of British Columbia, VAL anticipates participation in selective clinical trial programs researching the efficacy of medical cannabis.
The Company is about to close the signed Share Exchange Agreement (SEA) with Supra THC Services Inc. (“Supra”) which will become a wholly-owned subsidiary. Supra holds a Health Canada Dealer’s Licence and is providing sector-leading analytical services for Licensed Producers and ACMPR patients.
Connect with Valens GroWorks Corp. (CSE:VGW) to receive an Investor Presentation.
Beleave Inc. is a biotech company committed to becoming a licensed producer under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR“). Beleave’s wholly-owned subsidiary First Access Medical Inc. (“FAM“) has applied for a license to cultivate and sell medical cannabis pursuant to the ACMPR. As of the date hereof, FAM has successfully advanced past the review stage, and scheduled its pre-licensing inspection. Beleave’s purpose-built facility is located near Hamilton, Ontario.
This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the completion of the ACMPR licensing process, meeting the requirements of the ACMPR, obtaining a license to cultivate pursuant to the ACMPR, and the start of production. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com.
For more information contact:
Sebastian de Kloet
Phone: 1 (905) 979 – 5173
VANCOUVER, BC / TheNewswire / March 9, 2017 – Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS).
Mr. Dan Kriznic, director of Invictus MD Strategies Corp. (the “Issuer”), announces that on March 2, 2017, he was granted stock options (the “Options”) to purchase 1,000,000 common shares of the Issuer exercisable at a price of $1.75 per common share on or before March 2, 2022.
Prior to the grant of Options, Mr. Kriznic had ownership and control, directly and indirectly, of 2,308,204 common shares, 85,000 warrants and 1,555,000 stock options of the Issuer, representing approximately 6.07% of the issued and outstanding common shares of the Issuer on a non-diluted basis and approximately 9.96% of the issued and outstanding common shares of the Issuer when assuming exercise of all 85,000 warrants and 1,555,000 stock options held by Mr. Kriznic.
Immediately after the grant of Options, Mr. Kriznic had ownership and control, directly and indirectly, of 2,308,204 common shares, 85,000 warrants and 2,555,000 stock options of the Issuer, representing approximately 6.07% of the issued and outstanding common shares of the Issuer on a non-diluted basis and approximately 12.17% of the issued and outstanding common shares of the Issuer when assuming exercise of all 85,000 warrants and 2,555,000 stock options held by Mr. Kriznic.
A copy of the early warning report in respect of the foregoing matters has been filed under the Issuer’s profile on the System for Electronic Document Analysis and Review (SEDAR) at www.sedar.com. You may also contact Dan Kriznic, Chairman & CEO of the Issuer, in order to obtain a copy of the early warning report at Suite 3123 – 595 Burrard Street, PO Box 49139, Three Bentall Centre, Vancouver, BC V7X 1J1 or at (604) 368-6437.
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp. is focused on three main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR; Fertilizer and Nutrients through Future Harvest Development Ltd.; and Cannabis Data and Delivery, with its wholly owned subsidiary Poda Technologies Ltd.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,
Chairman & CEO
Vice President, Marketing & Communications
Vancouver, British Columbia, Canada, March 8, 2017 – Fundamental Applications Corp. (“Fundamental”) (CSE:FUN, FSE: 2FA, OTCQB: FUAPF) a leading developer of innovative smartphone applications, announces that it will launch its first app focused on the global cannabis user marketplace.
Fundamental will launch Citizen Green, a dedicated app built on the proven Foro buy/sell code base. Citizen Green will provide users with global information on cannabis related products, with options on where to purchase cannabis safely and legally, and will provide a forum to interconnect the cannabis community. The app will be available on both Apple and Google App stores March 25, 2017, in select European Union (“EU”) countries.
With 43 countries moving to either a legal medical marijuana program or to complete decriminalization, the global cannabis market is expected to grow close to 40% during the period 2016-2020. According to Research and Markets, a market research store, estimates the size of the EU cannabis market alone are as high as €35 billion per year (reference: http://www.researchandmarkets.com/reports/3883932/global-legal-marijuana-market-2016-2020). Additionally, Research and Markets’ “Global Legal Marijuana Market 2016-2020” report stated that “many vendors are using the internet to reach a large number of its targeted audience through online and mobile advertisements.”
“With the above quote in mind we are very proud to launch Citizen Green. Building a seamless platform that facilitates the relationship between marijuana growers and their customers is the core essence of what Fundamental brings to the market. The current environment for these brands to reach their clients digitally is extremely difficult but the launch of Citizen Green will give us the opportunity to make that connection,” comments Brad Moore, CEO of Fundamental.
Fundamental will use its existing code base for rapid expansive growth with dispensaries, pharmacies and retailers. With a secure login, product information can be uploaded to reach Fundamental’s current global base of 300,000 users. The Citizen Green app will also assist EU governments to clearly communicate cannabis regulations and laws to all citizens.
Mr. Moore further states, “With a commitment to creating value to our shareholders, Fundamental is aggressively moving forward in this sector as the research we have done over the last number of months clearly outlines significant growth opportunities. We are uniquely situated to go to market with a mix of the right technology, brand and users to become a major player in this exciting market.”
Fundamental Applications Corp. (CSE: FUN, FSE: 2FA, OTCQB: FUAPF) designs, develops, markets, and acquires innovative mobile applications targeted at the “Millennials” generation, people born in an age of digital technology, internet access, and smart phones. This demographic is an early adopter of mobile technology, has significant discretionary income, and is lifestyle driven with a willingness to try new things. Fundamental’s three leading mobile platforms are Foro, a peer-to-peer mobile ecommerce marketplace; Truth, a one-to-one anonymous messaging app previously listed in the top 100 social networking apps in the Apple App Store; and Opinit, an app that enables users to socially share their favourite online sentiment-driven content.
For more information about Fundamental Applications Corp., visit online at www.FunAppCorp.com, or review its company profiles on the SEDAR website (www.sedar.com) and on the Canadian Securities Exchange’s website (www.thecse.com). To schedule an interview, please contact:
Chief Executive Officer
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information. The Company has no intention or obligation to update or revise any forward looking statements due to new information or events.
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of Fundamental. Forward-looking information is based on certain key expectations and assumptions made by the management of Fundamental. Although Fundamental believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because Fundamental can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. Fundamental disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.